EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ScFv-h3D6 Prevents Bapineuzumab-Induced Hemorrhagic Events in the APP23 Mouse Model of Alzheimer’s Disease

Silvia Lope-Piedrafita iD, Gabriel Serra-Mir, Paula Melón, Anna Bonaterra iD, Mar Hernández-Guillamon iD, Sandra Villegas iD

Biomolecules · 2025

DOI: 10.3390/biom15111602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Silvia Lope-Piedrafita und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unitat de Biofísica, Departament de Bioquímica i Biologia Molecular, Facultat de Medicina, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Va…. Hauptthemen laut MEDLINE: Alzheimer Disease, Single-Chain Antibodies, Antibodies, Monoclonal, Humanized. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Economía y Empresa, Spain, Instituto de Salud Carlos III, Ministerio de Economía y Empresa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The occurrence of amyloid-related imaging abnormalities (ARIAs), found in clinical trials for Aβ-immunotherapy, has been related to the antibody’s effector function on glial activation by the Fc portion of the antibody. The use of single-chain variable fragments (scFv) has been proposed as a safer therapeutic strategy. Here, the effects of the mice format of bapineuzumap (mAb-m3D6) and its scFv (scFv-h3D6) on the occurrence of ARIAs in the APP23 mouse model of Alzheimer’s disease (AD) and cerebral amyloid angiopathy (CAA) have been addressed by magnetic resonance imaging (MRI). Results are supported by histological and/or biochemical determinations. Aged APP23 mice showed a significantly higher number of microhemorrhages than non-transgenic mice. mAb-m3D6 produced an increase in the number of new hemorrhagic events, mainly in the cortex, whereas scFv-h3D6 did not. Both mAb-m3D6 and scFv-h3D6 reduced Aβ levels by the same extent. Axonal/myelin damage was found in the frontal corpus callosum of APP23 mice, which did not recover after treatment. In conclusion, the scFv-h3D6 format appears safer than the full-length mAb in the APP23 model of AD and CAA. This finding is highly relevant in light of the new FDA- and EMA-approved mAbs, which exclude APOEε4 allele carriers due to the occurrence of hemorrhages.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseSingle-Chain AntibodiesAntibodies, Monoclonal, HumanizedAnimalsMiceDisease Models, AnimalMice, TransgenicHumansAmyloid beta-PeptidesCerebral Amyloid AngiopathyMagnetic Resonance ImagingAmyloid beta-Protein Precursor

Stichwörter der Autor:innen

Alzheimer’s diseaseamyloid-related imaging abnormalitiescerebral amyloid angiopathyimmunotherapymagnetic resonance imagingsingle-chain variable fragment

Substanzen

Single-Chain AntibodiesbapineuzumabAntibodies, Monoclonal, HumanizedAmyloid beta-PeptidesAmyloid beta-Protein Precursor

Autor:innen und Institutionen

  • Unitat de Biofísica, Departament de Bioquímica i Biologia Molecular, Facultat de Medicina, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.
  • Servei de Ressonància Magnètica Nuclear, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.
  • Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.
  • Protein Design and Immunotherapy Group, Departament de Bioquímica i Biologia Molecular, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.
  • Neurovascular Research Laboratory, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.

ORCID-Profile: Silvia Lope-Piedrafita, Anna Bonaterra, Mar Hernández-Guillamon, Sandra Villegas

Förderung

  • Ministerio de Economía y Empresa, Spain
  • Instituto de Salud Carlos III
  • Ministerio de Economía y Empresa

Zitieren

APA

Lope-Piedrafita, S., Serra-Mir, G., Melón, P., Bonaterra, A., Hernández-Guillamon, M., & Villegas, S. (2025). ScFv-h3D6 Prevents Bapineuzumab-Induced Hemorrhagic Events in the APP23 Mouse Model of Alzheimer’s Disease. Biomolecules. https://doi.org/10.3390/biom15111602

Vancouver

Lope-Piedrafita S, Serra-Mir G, Melón P, Bonaterra A, Hernández-Guillamon M, Villegas S. ScFv-h3D6 Prevents Bapineuzumab-Induced Hemorrhagic Events in the APP23 Mouse Model of Alzheimer’s Disease. Biomolecules. 2025. doi:10.3390/biom15111602

BibTeX
@article{LopePiedrafita2025,
  author = {Lope-Piedrafita, Silvia and Serra-Mir, Gabriel and Melón, Paula and Bonaterra, Anna and Hernández-Guillamon, Mar and Villegas, Sandra},
  title = {ScFv-h3D6 Prevents Bapineuzumab-Induced Hemorrhagic Events in the APP23 Mouse Model of Alzheimer’s Disease},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15111602}
}
Kostenlos starten →